´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ¼¿ïµå·¹°ï½ÃƼȣÅÚ(ÇѶóA,B,C·ë)
±³À°ÁÖÁ¦ : 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѳúÀüÁõÇÐȸ
´ã´çÀÚ : ÀÌ°¡¿¬
¿¬¶ôó : 02-362-9662
À̸ÞÀÏ : epilepsy@kes.or.kr
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°ÀÇÇаú, ½Å°æ¿Ü°ú, ½Å°æ°ú, ÀÇ»çÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í [»çÀüµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø): 100,000¿ø ÁØȸ¿ø(Àü°øÀÇ): 30,000¿ø ºñȸ¿ø : 180,000¿ø ±â»ç,°£È£»ç,¿¬±¸¿ø : ¹«·á [ÇöÀåµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø) : 120,000¿ø ÁØȸ¿ø(Àü°øÀÇ) : 50,000¿ø ºñȸ¿ø : 200,000¿ø ±â»ç,°£È£»ç,¿¬±¸¿ø : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 08:30~08:45 Case 1. Diagnosis and treatment of patients resenting with pain as a symptom of epilepsy: navigating the challenges À̵¿¾Æ(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë ¹éº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 08:45~09:00 Case 2. The expedition to find focality in pharmacoresistant pediatric epilepsy ¾çµ¿È(°í·ÁÀÇ´ë ±¸·Îº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 09:00~09:15 Understanding pharmacokinetics and drug interactions of antiseizure medications through cases 1 Çã°æ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 09:15~09:30 Understanding pharmacokinetics and drug interactions of antiseizure medications through cases 2 Çã°æ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
ÈÞ½Ä 06¿ù 22ÀÏ 09:30~09:40 Coffee Break ()
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A+B 09:40~10:30 Presidential symposium. Identification of epileptic network using stereoelectroencephalography Fabrice Bartolomei (Aix-Marseille University)
ÈÞ½Ä 06¿ù 22ÀÏ 10:30~10:40 Coffee Break ()
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 10:40~11:00 Hippocampus and Imagination Á¤¹Îȯ(Çѱ¹°úÇбâ¼ú¿ø(KAIST))
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 11:00~11:20 Uric acid and seizure disorder from bedside to bench ÃÖÁØ¿µ(¾ÆÁÖÀÇ´ë ¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 11:40~12:20 Two-year experience with Zebinix in single tertiary center ±èµ¿¿í(°Ç±¹ÀÇ´ë °Ç±¹´ëº´¿ø)
ÈÞ½Ä 06¿ù 22ÀÏ 12:20~12:30 Coffee Break ()
±âŸ 06¿ù 22ÀÏ 12:30~13:30 Poster presentation ()
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 13:30~13:50 Basic principles and clinical application of MEG in Korea È«½ÂºÀ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 13:50~14:10 MEG and epilepsy surgery Àå¿ø¼®(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:10~14:30 MEG-based brain mapping for epilepsy and other diseases Nobukazu Nakasato (Tohoku University School of Medicine)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:30~14:50 Zebrafish EEG predicts the efficacy of antiseizure medications ±è¼ÒÈñ(´ë±¸°æºÏ°úÇбâ¼ú¿ø(DGIST))
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:50~15:10 The role of animal models in drug repurposing for developmental and epileptic encephalopathies ±è¹ÎÁö(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 15:10~15:30 Is there a promise of precision medicine using current gene editing therapies for developmental and epileptic encephalopathies °í¾Æ¶ó(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
ÈÞ½Ä 06¿ù 22ÀÏ 15:30~15:40 Coffee Break ()
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 15:40~16:00 Incidence of seizures and risk of epilepsy in autoimmune encephalitis ÁÖ°Ç(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:00~16:20 Clinical and electroencephalographic features of epileptic seizures in autoimmune encephalitis ÀÌ¿ìÁø(¼¿ïÀÇ´ë ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:20~16:40 Management and long-term outcomes of epileptic seizures in autoimmune encephalitis ¼±¿ìÁØ»ó(¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:40~17:00 Freud and psychogenic non-epileptic seizures David Y. Ko(Loma Linda VA Medical Center)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 17:00~17:20 Electroencephalographic and imaging features of psychogenic non-epileptic seizures ±è¼ºÈÆ(°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 17:20~17:40 Proper management of psychogenic non-epileptic seizures ±è¿ìÁØ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 08:30~08:45 NCSE in critically ill patients should be treated aggressively ±è¿µ¼ö(°æ»óÀÇ´ë °æ»ó´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 08:45~09:00 NCSE in critically ill patients should NOT be treated aggressively ÀÓ¼ºÃ¶(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 09:00~09:15 Focal-aware SE should be treated aggressively ±è¿µ¼ö(°æ»óÀÇ´ë °æ»ó´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 09:15~09:30 Focal-aware SE should NOT be treated aggressively ÀÓ¼ºÃ¶(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 10:40~11:00 Epilepsy diagnosis and syndromic classification ¹®ÁøÈ(ÇѾçÀÇ´ë ±¸¸®º´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:00~11:20 Seizure intractability and drug response Ji Yeoun Yoo(Icahn School of Medicine at Mount Sinai )
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:20~11:40 Cognitive and behavioral consequences À̺¸·Ã(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:40~12:20 Lacosamide as an alternative treatment option in status epilepticus ÀÌÁöÈÆ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 13:30~13:50 New landscape of epilepsy surgery: SEEG guided, less invasive surgery and neuromodulation ¼Õ¿µ¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 13:50~14:10 A Novel Method for Detecting High-Frequency Oscillations with High Specificity Hohyun Cho(Washington University School of Medicine in St. Louis, Missouri, USA)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:10~14:30 Usefulness of SEEG in epilepsy surgery: experiences in Nishiniigata Chuo Hospital Masafumi Fukuda (Nishi Niigata Chuo National Hospital)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:30~14:50 EPIDIOLEX¢ç (cannabidiol), an FDA-approved drug for Lennox-Gastaut syndrome Yong D. Park(Augusta University )
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:50~15:10 Corpus callosotomy and vagus nerve stimulation for Lennox-Gastaut syndrome Joo Hee Seo(AdventHealth for Children)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 15:10~15:30 Deep brain stimulation of thalamic centromedian nucleus for Lennox-Gastaut syndrome Hyunmi Kim(Stanford University)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 15:40~16:00 Challenging clinical situation in refractory status epilepticus: NORSE Ji Yeoun Yoo(Icahn School of Medicine at Mount Sinai )
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:00~16:20 Challenging clinical situation in refractory status epilepticus: FIRES °ÁØ¿ø(Ãæ³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:20~16:40 Preclinical models of NORSE/FIRES: how and why Sookyong Koh (University of Nebraska )
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:40~17:00 Epidemiology of cognitive comorbidities in epilepsy ÃÖ¼±¾Æ(ÀÌÈÀÇ´ë ¸ñµ¿º´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 17:00~17:20 Interictal epileptiform activity and cognitive comorbidities: intracranial EEG study ±è¿ìÁß(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 17:20~17:40 Deciphering epilepsy-associated comorbidities through hippocampal neurogenesis Á¶°æ¿Á(°¡Å縯ÀÇ´ë ¾à¸®Çб³½Ç)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 09:40~11:40 Curry hands-on practice ±¸¿ë¼(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 13:30~15:30 Epidemiologic Study for Seizure and Epilepsy using Nationwide database for Corean Epilepsy patients (ESSENCE) study group À̼¿µ(°¿øÀÇ´ë °¿ø´ëº´¿ø)
±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 15:40~17:40 consideration for clinical cde deployment: clinical use vs. research application ¼Õ¿µ¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)